Here’s a practical side‑by‑side of griseofulvin vs itraconazole.
- Mechanism and spectrum
- Griseofulvin: fungistatic. Binds to keratin and inhibits fungal mitosis; mainly dermatophytes (Tinea species) that infect skin, hair, and nails. Poor activity against yeasts and molds.
- Itraconazole: fungistatic (often fungicidal against some fungi). Inhibits fungal ergosterol synthesis (CYP51). Broad spectrum: dermatophytes, yeasts (Candida, Malassezia), and some molds; useful for systemic infections and nail disease.
- Indications and typical targets
- Griseofulvin: traditional option for dermatophyte infections of skin and hair; historically used for tinea capitis (especially in children) and some nail issues, but less preferred today for nails due to slower, unreliable nail clearance.
- Itraconazole: more versatile—dermatophytes, Cryptococcus, Candida, some dimorphic fungi; commonly used for tinea capitis, tinea corporis/pedis, onychomycosis, and certain systemic fungal infections. Often preferred for nails and systemic involvement.
- Administration and pharmacokinetics
- Griseofulvin: oral only. Lipid‑soluble with long duration of therapy; induces hepatic enzymes (drug interactions are common). Absorption can be variable; taken with fatty meals to improve absorption.
- Itraconazole: oral or IV. Absorption higher with certain formulations; absorption can be pH dependent (capsules require gastric acid; interactions with antacids and proton pump inhibitors can affect levels). Metabolized by the liver; significant drug interactions via CYP3A4.
- Safety, monitoring, and cautions
- Griseofulvin: photosensitivity, GI upset, headaches; potential liver effects; teratogenic risk—contraindicated in pregnancy; induces many drug‑metabolizing enzymes (can reduce levels of other drugs such as warfarin, oral contraceptives, cyclosporine).
- Itraconazole: hepatotoxicity risk (monitor LFTs); potential QT prolongation and negative inotropy (heart failure risk); many drug–drug interactions via CYP3A4; also contraindicated in pregnancy by many guidelines; caution with cardiac disease.
- Practical considerations and duration
- Griseofulvin: longer, disease‑specific courses (e.g., skin infections may require weeks; nails can take many months). Generally reserved for certain dermatophyte infections or in settings where itraconazole is not suitable.
- Itraconazole: more convenient and effective for many dermatophyte infections and especially for nails and systemic infections. Typical regimens for nails include 12 weeks of continuous therapy (or pulsed dosing like 1 week on/1 week off for several cycles, depending on the protocol and organism). Always tailor to organism and site of infection.
- When to choose which (quick guide)
- Choose griseofulvin if: a dermatophyte skin/hair infection where its use is appropriate and there are no better options, and you want a cheaper, older agent with a long track record. Be mindful of interactions and teratogenic risk.
- Choose itraconazole if: you need broader coverage (including nails and certain systemic infections), or if you want a shorter, more convenient course for dermatophyte infections or onychomycosis, while proactively managing liver function and drug interactions.
- Special notes
- For nail infections (onychomycosis), itraconazole or terbinafine are generally preferred today over griseofulvin due to better efficacy and nail penetration (though exact choice depends on organism, patient factors, and local guidelines).
- Pregnancy: both are generally avoided; griseofulvin is classically avoided in pregnancy due to teratogenic concerns, and itraconazole is usually avoided as well.
If you have a specific infection (e.g., tinea capitis in a child, onychomycosis in an adult, or a systemic fungal infection) I can tailor a more precise comparison, including typical regimens and monitoring.